Clinical trials
Completed Endocrine System Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascendis Pharma Endocrinology Division A/S | 3 |
| Eli Lilly and Company | 2 |
| AbbVie | 1 |
| Ascendis Pharma A/S | 1 |
| Ascendis Pharma Bone Diseases A/S | 1 |
| Celgene | 1 |
| Hoffmann-La Roche | 1 |
| IRCCS Centro Neurolesi Bonino Pulejo | 1 |
| Istituto Auxologico Italiano | 1 |
| National Center for Research Resources (NCRR) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 15 |
| Adenocarcinoma | 3 |
| Diabetes Mellitus | 3 |
| Digestive System Diseases | 3 |
| Digestive System Neoplasms | 3 |
| Dwarfism, Pituitary | 3 |
| Endocrine Gland Neoplasms | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Diabetes Mellitus, Type 2 | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.